Techwald Holding

Techwald Holding is a participation holding company based in Turin, Italy, founded in 2014. It focuses on scouting, investing in, and supporting early-stage companies with high growth potential in the field of healthcare innovation, particularly in medical technologies. By targeting promising startups, Techwald aims to foster advancements in healthcare through strategic investments and active support.

Luca Binda PhD MBA

Managing Partner and Investment Director

8 past transactions

Lymphatica Medtech

Series B in 2024
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.

SentiAR

Series B in 2023
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

SoniVie

Series C in 2023
SoniVie is engaged in the development of a medical device aimed at treating pulmonary hypertension through advanced denervation techniques. The company’s device involves a catheter that is inserted into the pulmonary artery during a minimally invasive procedure. This device selectively targets and damages the nerves linked to the disease without affecting the vessel walls or surrounding tissues, allowing physicians to effectively address the condition.

Beyeonics

Venture Round in 2021
Beyeonics specializes in advanced surgical visualization technologies, aiming to enhance the information available to surgeons during procedures. Established in 2012 by a team of experienced engineers, the company is based in Israel and is developing innovative platforms that utilize augmented and virtual reality to replace traditional surgical microscopes. This technology allows for the real-time integration of vast amounts of data, which significantly improves surgical efficiency and patient safety. Beyeonics is focused on expanding its offerings to various surgical applications, including spine surgery, minimally invasive procedures, robotic surgery, and cardiovascular catheterization. The company collaborates with notable medical professionals, including those from the Tel Aviv Sourasky Medical Center and Retinal Consultants of Arizona, to ensure that its solutions meet the evolving needs of the medical community.

SentiAR

Series A in 2021
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

NitiNotes

Series A in 2018
NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.

Bendit

Convertible Note in 2018
Bendit is a medical company focused on the development and manufacturing of innovative catheters that utilize a unique bending technology, allowing for enhanced steering capabilities in both micro diameter and traditional catheter designs. The company specializes in creating microcatheter devices that facilitate optimal navigation within the body, particularly in challenging anatomical areas. Bendit's products are designed to improve procedural efficiency by enabling healthcare professionals to reach target sites with fewer tools, thereby reducing risks and increasing the likelihood of successful outcomes. The organization is a joint venture comprising three experienced groups that bring expertise in production, quality and regulation, and medical development.

Bendit

Series A in 2017
Bendit is a medical company focused on the development and manufacturing of innovative catheters that utilize a unique bending technology, allowing for enhanced steering capabilities in both micro diameter and traditional catheter designs. The company specializes in creating microcatheter devices that facilitate optimal navigation within the body, particularly in challenging anatomical areas. Bendit's products are designed to improve procedural efficiency by enabling healthcare professionals to reach target sites with fewer tools, thereby reducing risks and increasing the likelihood of successful outcomes. The organization is a joint venture comprising three experienced groups that bring expertise in production, quality and regulation, and medical development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.